AGC Director Dr. John Klassen's article on "Screening Natural Libraries of Human Milk Oligosaccharides Against Lectins Using CaR-ESI-MS" has been accepted for publication in Analyst, the home of premier fundamental discoveries, inventions and applications in the analytical and bioanalytical sciences published by the Royal Society of Chemistry.
Developing a new drug starts with identifying the molecule or "ligand" that can block the molecular target or "receptor" involved in a disease. Even with high throughput screening, finding that one functional ligand for a receptor from a haystack of millions of possible compounds is expensive, high–risk and time–consuming. Converting a promising target into a commercial drug typically takes about 15 years and costs up to $800 million. To accelerate the discovery process, Canadian Glycomics Network (GlycoNet), in partnership with the Alberta Glycomics Centre (AGC) and the Derda Research Group at the University of Alberta (U of A), launched a… read more >>
Bennett Jones is pleased to announce it is now providing intellectual property services to the Alberta Glycomics Centre. The Centre is home to some of the world’s most accomplished experts in carbohydrate-based research and is located at the University of Alberta. The focus of the Centre’s research is understanding the interactions of carbohydrates at the molecular level and applying the knowledge toward medical and commercial uses. These include projects designed to develop vaccines against tuberculosis, bloodstream infections in hospitalized patients, various cancers and Alzheimer’s disease. “The Alberta Glycomics Centre has been a leader in innovation and commercialization in Alberta and… read more >>
AGC Core Services manager Daniel Hernandez Armada has co-authored a paper on "Enzymatic conversion of lactose into galacto-oligosaccharides" that has been accepted for publication in the Journal of Food Engineering. Click here for PDF version.
Pleased to report that the European Patent Office (EPO) has issued a decision to grant a European patent pursuant to Article 97(1) EPC to our technology titled "Methods and Systems for O-Glycosylating Proteins." Another successful development in our IP portfolio. Congratulations to all involved with developing and guiding this technology through the patent process.
A field at the forefront of biomedical science, glycosciences is the study of complex roles for carbohydrates--also described as oligosaccharides or glycans--in biological systems. Going far beyond a role as an energy source, carbohydrates orchestrate many critical cellular processes, all the way from fertilization to programmed cell death. Click here for full article. Published originally by U of A Faculty of Science on November 2, 2017